ECARX Announces Board Changes
LONDON, Jan. 05, 2024 (GLOBE NEWSWIRE) — ECARX Holdings Inc. (Nasdaq: ECX) (“ECARX” or the “Company”), a global mobility tech […]
Semantix Provides Update Regarding Nasdaq Minimum Bid Price Compliance
SÃO PAULO, Brazil, Jan. 05, 2024 (GLOBE NEWSWIRE) — Semantix, Inc. (NASDAQ: STIX), a leading Latin American enterprise AI platform […]
Triumph Financial Announces Schedule for Fourth Quarter 2023 Earnings Release and Conference Call
DALLAS, Jan. 05, 2024 (GLOBE NEWSWIRE) — Triumph Financial, Inc. (Nasdaq: TFIN) today announced that it expects to release its […]
Societal CDMO Reports Inducement Grants for New Staff
SAN DIEGO and GAINESVILLE, Ga., Jan. 05, 2024 (GLOBE NEWSWIRE) — Societal CDMO, Inc. (“Societal CDMO”; NASDAQ: SCTL), a contract […]
Regeneron to Report Fourth Quarter and Full Year 2023 Financial and Operating Results and Host Conference Call and Webcast on February 2, 2024
TARRYTOWN, N.Y., Jan. 05, 2024 (GLOBE NEWSWIRE) — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its […]
A-Mark Precious Metals Announces Quarterly Cash Dividend
EL SEGUNDO, Calif., Jan. 05, 2024 (GLOBE NEWSWIRE) — A-Mark Precious Metals, Inc. (NASDAQ: AMRK) (A-Mark), a leading fully integrated […]
Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
BRISBANE, Calif., Jan. 05, 2024 (GLOBE NEWSWIRE) — Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage oncology company developing first-in-class1 therapeutics […]
Senti Bio Announces Strategic Steps to Prioritize Investment in Lead Clinical Program
– Strategic resource allocation to focus investment on clinical development of SENTI-202 and SENTI-301A partnership in China; interim data from […]
Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BOSTON, Mass., Jan. 05, 2024 (GLOBE NEWSWIRE) — Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering […]
Barinthus Bio Provides a Financial Update and Announces Anticipated 2024 Corporate Milestones
Cash runway anticipated to be extended from Q2 2025 to Q4 2025 Data from multiple Phase 1 and 2 clinical […]
